Screening mammography was assessed in 9 randomized trials initiated between 1963 and
1990, with breast cancer-specific mortality as the primary endpoint. In contrast, breast cancer …

It is desirable to have a strategy for evaluation of breast cancer service screening programs
years before the long‐term breast cancer mortality data are available. Since successful …

One of the greatest successes in cancer control has been the dramatic decline in the death
rate from breast cancer over the past 20 years in the United States. In 1989, the death rate …

BACKGROUND: It has recently been suggested that all-cause mortality is a more
appropriate end point than disease specific mortality in cancer screening trials, and that …

Another spirited debate has ensued over the benefits of breast cancer screening, 1 freshly
stimulated by the recent publication of the 25-year follow-up results of the Canadian …

Breast cancer screening has provoked some of the more intensive debate in medicine.
Breast cancer is an appropriate disease for screening based on accepted criteria: Current …

Using published data from screening trials, this article compares two-modality
(mammography and clinical examination) and single-modality (clinical examination alone) …

Importance The age-based or “one-size-fits-all” breast screening approach does not take
into account the individual variation in risk. Mammography screening reduces death from …

Breast cancer is the most commonly diagnosed cancer in women in the United States, the
second leading cause of cancer deaths, and the single leading cause of death in women …

The balance between benefits and harms is delicate for cancer screening programs. By
attending screening with mammography some women will avoid dying from breast cancer or …